Umasuthan Srirangalingam, FRCP, PhD

University College London Hospitals
London, England, United Kingdom

Disclosure information not submitted.

Presentation(s):

• ORF32-04 - Once Daily Atumelnant (CRN04894) Enables Lowering of Glucocorticoid Doses with Sustained Androgen Reduction in Adults with Congenital Adrenal Hyperplasia

  Sunday, June 14, 2026
  2:10 PM - 2:25 PM CT

• ORF32-07 - Crinecerfont Improves Weight-Related Outcomes and Insulin Resistance in Adults with Classic Congenital Adrenal Hyperplasia: 2-Year Results from the CAHtalyst™ Adult Study

  Sunday, June 14, 2026
  2:55 PM - 3:10 PM CT